Morelli MC - Search Results

1

Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial.

Ravaioli M, Neri F, Lazzarotto T, Bertuzzo VR, Di Gioia P, Stacchini G, Morelli MC, Ercolani G, Cescon M, Chiereghin A, Del Gaudio M, Cucchetti A, Pinna AD. Ravaioli M, et al. Among authors: morelli mc. Transplantation. 2015 Aug;99(8):1625-32. doi: 10.1097/TP.0000000000000650. Transplantation. 2015. PMID: 25757214 Clinical Trial.

2

Differential induction of Fos-like-immunoreactivity in the extended amygdala after haloperidol and clozapine.

Pinna A, Morelli M. Pinna A, et al. Neuropsychopharmacology. 1999 Jul;21(1):93-100. doi: 10.1016/S0893-133X(98)00136-5. Neuropsychopharmacology. 1999. PMID: 10379523

3

Antidepressants and atypical neuroleptics induce Fos-like immunoreactivity in the central extended amygdala.

Morelli M, Pinna A. Morelli M, et al. Ann N Y Acad Sci. 1999 Jun 29;877:703-6. doi: 10.1111/j.1749-6632.1999.tb09306.x. Ann N Y Acad Sci. 1999. PMID: 10415688 No abstract available.

4

Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.

Pinna A, Fenu S, Morelli M. Pinna A, et al. Synapse. 2001 Mar 1;39(3):233-8. doi: 10.1002/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K. Synapse. 2001. PMID: 11284438

5

Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease.

Morelli M, Pinna A. Morelli M, et al. Neurol Sci. 2001 Feb;22(1):71-2. doi: 10.1007/s100720170052. Neurol Sci. 2001. PMID: 11487207

6

Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats.

Simola N, Tronci E, Pinna A, Morelli M. Simola N, et al. Amino Acids. 2006 Nov;31(4):359-63. doi: 10.1007/s00726-006-0373-3. Epub 2006 Aug 2. Amino Acids. 2006. PMID: 16874467

7

Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions.

Simola N, Morelli M, Pinna A. Simola N, et al. Curr Pharm Des. 2008;14(15):1475-89. doi: 10.2174/138161208784480072. Curr Pharm Des. 2008. PMID: 18537671 Review.

8

Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant.

Biselli M, Vitale G, Gramenzi A, Riili A, Berardi S, Cammà C, Scuteri A, Morelli MC, Grazi GL, Pinna AD, Andreone P, Bernardi M. Biselli M, et al. Among authors: morelli mc. Clin Transplant. 2009 Mar-Apr;23(2):191-8. doi: 10.1111/j.1399-0012.2009.00965.x. Epub 2009 Feb 4. Clin Transplant. 2009. PMID: 19210525

9

Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.

Cescon M, Grazi GL, Cucchetti A, Vetrone G, Ravaioli M, Ercolani G, Morelli MC, Piscaglia F, Tamè M, Pinna AD. Cescon M, et al. Among authors: morelli mc. Liver Transpl. 2009 Jul;15(7):782-9. doi: 10.1002/lt.21760. Liver Transpl. 2009. PMID: 19562715 Free article.

10

Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically.

Morelli MC, Sambri V, Grazi GL, Gaibani P, Pierro A, Cescon M, Ercolani G, Cavrini F, Rossini G, Capobianchi MR, Di Caro A, Menzo S, Pagliaro PP, Ghinelli F, Lazzarotto T, Landini MP, Pinna AD. Morelli MC, et al. Clin Infect Dis. 2010 Aug 15;51(4):e34-7. doi: 10.1086/655146. Clin Infect Dis. 2010. PMID: 20597692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters